跳至主要内容
临床试验/NCT01705925
NCT01705925已完成不适用

Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome

Pediatrix1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Pediatrix
入组人数
92
试验地点
1
主要终点
Adverse Cardiac Events on patients with genotype positive LQT1 who have a normal EKG and absence of symptoms, but a molecular confirmation of LQT1.

研究概览

简要总结

The purpose of the study is to provide comprehensive follow-up in patients with Long QT Syndrome (LQTS) and gain additional information regarding genotype-phenotype correlation and effective management and treatment options.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children and/or young adults diagnosed with heterogeneous repolarization disorder who have genotype positive Long QT, or
  • Newly diagnosed mutation positive patients with a confirmed test

排除标准

  • Children who are phenotypically positive with no molecular testing
  • Children that are phenotypically positive but genotype negative

结局指标

主要结局

Adverse Cardiac Events on patients with genotype positive LQT1 who have a normal EKG and absence of symptoms, but a molecular confirmation of LQT1.

时间窗: Enrollment is expected to take approximately 5 years. The patients will be followed until they are no longer cared for by a pediatric cardiology facility (typically post-college) or approximately 21 years of age.

次要结局

  • Adverse Cardiac Events on patients with both phenotype and genotype positive.(Enrollment is expected to take approximately 5 years. The patients will be followed until they are no longer cared for by a pediatric cardiology facility (typically post-college) or approximately 21 years of age.)

研究者

发起方
Pediatrix
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验